/
INM
$1.46-$0.01 (-0.69%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$7.7M
5M shares
52-week range
$0.58 – $2.50
46% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-1173.57
InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
www.inmedpharma.com- Employees
- 13
- IPO / List date
- Nov 10, 2020
- HQ
- VANCOUVER, A1
Held by traders on TradeandTell
No one on the platform currently holds INM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 16,800 | $36.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-11-14 | 1-for-20reverse |
| 2022-09-07 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded INM yet.
